Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL5862 Target Snapshot

Glucagon-like peptide 1 receptor · SINGLE PROTEIN · Rattus norvegicus

82Compounds
25Assays
1Approved Drugs
134.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P32301. Use UniProt P32301 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P32301 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Glucagon-like peptide 1 receptor as ChEMBL target CHEMBL5862, mapped to UniProt P32301. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Glucagon-like peptide 1 receptor
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL5862
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P32301
Glucagon-like peptide 1 receptor
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Glucagon-like peptide 1 receptor is the right protein anchor across sources, using UniProt P32301 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelGlucagon-like peptide 1 receptor
UniProt AccessionP32301
Component TypeProtein
Sequence Length463 aa

Glucagon-like peptide 1 receptor

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Glucagon-like peptide 1 receptor, mapped to UniProt P32301. Sequence length is 463 aa.

Mapped IDP32301
Review nameGlucagon-like peptide 1 receptor
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC5064.0
KI2.0
EC5068.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2158410 10.05 EC50 0.09 Preclinical
CHEMBL4749279 9.92 EC50 0.12 Preclinical
CHEMBL414357 9.85 IC50 0.14 Approved
CHEMBL4066463 9.6 EC50 0.25 Preclinical
CHEMBL5208485 9.6 EC50 0.25 Preclinical
CHEMBL1092704 9.43 IC50 0.37 Preclinical
CHEMBL1092373 9.32 IC50 0.48 Preclinical
CHEMBL4751466 9.32 EC50 0.48 Preclinical
CHEMBL1092706 9.26 IC50 0.55 Preclinical
CHEMBL1092708 9.24 IC50 0.58 Preclinical
Distribution

pChEMBL Value Distribution

18
5.0
20
5.5
11
6.0
7
6.5
2
7.0
1
7.5
2
8.0
1
8.5
7
9.0
4
9.5
pChEMBL
Approved Drugs

Approved Drugs

EXENATIDE
CHEMBL414357
Approved 2005
Assay Landscape

Assay Landscape

25
Total Assays
48
Tested Compounds
2
Assay Types
Binding — 15 assays, 48 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 14 48 6.6
single protein format 1 0
Functional — 10 assays, 27 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 10 27 6.2

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine